Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Interest Expenses (2019 - 2025)

Pulmonx (LUNG) has disclosed Interest Expenses for 7 consecutive years, with $805000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses fell 9.65% to $805000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $3.2 million, a 9.61% decrease, with the full-year FY2024 number at $3.5 million, up 8.51% from a year prior.
  • Interest Expenses was $805000.0 for Q3 2025 at Pulmonx, up from $799000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $905000.0 in Q4 2023 to a low of $198000.0 in Q1 2022.
  • A 5-year average of $580000.0 and a median of $781000.0 in 2025 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: crashed 81.23% in 2021, then surged 287.44% in 2023.
  • Pulmonx's Interest Expenses stood at $199000.0 in 2021, then skyrocketed by 80.4% to $359000.0 in 2022, then soared by 152.09% to $905000.0 in 2023, then decreased by 6.96% to $842000.0 in 2024, then decreased by 4.39% to $805000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Interest Expenses are $805000.0 (Q3 2025), $799000.0 (Q2 2025), and $781000.0 (Q1 2025).